tenk.fyi

Kalaris Therapeutics, Inc.

KLRSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$58.8M

69.1% YoY

EPS

$-11.73

72.1% YoY

Cash

$118.3M

31.3% YoY

FY 2024 · As of 2024-12-31